David Altshuler is EVP, Chief Scientific Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 25,813 shares of VRTX, which is worth approximately $11.9 Million. The most recent transaction as insider was on Feb 03, 2021, when has been sold 32,453 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.8K
0% 3M change
19.43% 12M change
Total Value Held $11.9 Million

DAVID ALTSHULER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2021
BUY
Grant, award, or other acquisition
-
32,453 Added 34.6%
61,355 Common Stock
Nov 16 2020
SELL
Open market or private sale
$8,491 $223.45 p/Share
38 Reduced 0.13%
28,902 Common Stock
DA

David Altshuler

EVP, Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX